Marcio Covas Moschovas1, Seetharam Bhat2, Travis Rogers2, Fikret Onol2, Shannon Roof2, Elio Mazzone3, Alexandre Mottrie4, Vipul Patel2. 1. AdventHealth Global Robotics Institute, Celebration, FL, USA; OLV Hospital, Orsi Academy, Melle, Belgium. Electronic address: marcio.doc@hotmail.com. 2. AdventHealth Global Robotics Institute, Celebration, FL, USA. 3. OLV Hospital, Orsi Academy, Melle, Belgium; San Raffaele Scientific Institute, Milan, Italy. 4. OLV Hospital, Orsi Academy, Melle, Belgium.
Abstract
BACKGROUND: Since the implementation of robotic surgery, the platforms have been updating constantly in terms of arm configuration, tool design, scope settings, and the number of trocars placed. The introduction of new robotic technology is challenging and requires studies followed by technique adaptions. OBJECTIVE: This study aims to report a logical and technologically safe approach to the learning curve using the da Vinci single-port (SP) console and describes our robotic-assisted radical prostatectomy (RARP) technique step by step. DESIGN, SETTING, AND PARTICIPANTS: A prospective study from 26 consecutive patients who underwent RARP with the da Vinci SP console from June to August 2019. SURGICAL PROCEDURE: All surgeries were performed with a transperitoneal technique; one robotic trocar was placed above the umbilicus and one additional 12 mm trocar was placed in the right lower quadrant. MEASUREMENTS: We described the step-by-step technique and reported the perioperative and pathological data. In addition, we considered the hospital length of stay and pain scale following surgery. Continuous variables were reported as median and interquartile ranges. Categorical variables were reported as frequencies and proportions. RESULT AND LIMITATIONS: The total median operative time was 121 min, console time was 85 min, and blood loss was 50 ml. No complications were reported. In the final pathology, four patients had Gleason 6, 20 had Gleason 7, one had Gleason 8, and one had Gleason 9.Of the patients, 70% were ≤pT2 and 30% were ≥pT3a. Only 11% had positive surgical margins. This study is limited by the small number of patients and a short period of follow-up to evaluate functional and oncological outcomes of this new technology. CONCLUSIONS: RARP with the da Vinci SP is feasible and safe. Therefore, the step-by-step technique described in this study could be considered an option to perform radical prostatectomies. However, we still need better-designed studies to compare the outcomes with those of the multiport platform. PATIENT SUMMARY: We reported our step-by-step technique describing a safe approach to robotic-assisted radical prostatectomy during the transition from the Xi to the da Vinci single-port robot.
BACKGROUND: Since the implementation of robotic surgery, the platforms have been updating constantly in terms of arm configuration, tool design, scope settings, and the number of trocars placed. The introduction of new robotic technology is challenging and requires studies followed by technique adaptions. OBJECTIVE: This study aims to report a logical and technologically safe approach to the learning curve using the da Vinci single-port (SP) console and describes our robotic-assisted radical prostatectomy (RARP) technique step by step. DESIGN, SETTING, AND PARTICIPANTS: A prospective study from 26 consecutive patients who underwent RARP with the da Vinci SP console from June to August 2019. SURGICAL PROCEDURE: All surgeries were performed with a transperitoneal technique; one robotic trocar was placed above the umbilicus and one additional 12 mm trocar was placed in the right lower quadrant. MEASUREMENTS: We described the step-by-step technique and reported the perioperative and pathological data. In addition, we considered the hospital length of stay and pain scale following surgery. Continuous variables were reported as median and interquartile ranges. Categorical variables were reported as frequencies and proportions. RESULT AND LIMITATIONS: The total median operative time was 121 min, console time was 85 min, and blood loss was 50 ml. No complications were reported. In the final pathology, four patients had Gleason 6, 20 had Gleason 7, one had Gleason 8, and one had Gleason 9.Of the patients, 70% were ≤pT2 and 30% were ≥pT3a. Only 11% had positive surgical margins. This study is limited by the small number of patients and a short period of follow-up to evaluate functional and oncological outcomes of this new technology. CONCLUSIONS: RARP with the da Vinci SP is feasible and safe. Therefore, the step-by-step technique described in this study could be considered an option to perform radical prostatectomies. However, we still need better-designed studies to compare the outcomes with those of the multiport platform. PATIENT SUMMARY: We reported our step-by-step technique describing a safe approach to robotic-assisted radical prostatectomy during the transition from the Xi to the da Vinci single-port robot.
Authors: Spyridon P Basourakos; Keith Kowalczyk; Marcio Covas Moschovas; Vanessa Dudley; Andrew J Hung; Jonathan E Shoag; Vipul Patel; Jim C Hu Journal: J Endourol Date: 2021-11 Impact factor: 2.942